OEC

Omega Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Wednesday, March 1, 2023
Acute respiratory distress syndrome, Safety, Therapy, Reuters, Culture, Investigational New Drug, Research, Lung cancer, Clinical trial, IND, G&A, Pharmacokinetics, Security, Part, FDA, Standard of care, Hepatocellular carcinoma, Patient, Multiple, R, Omega, NSCLC, OEC, OMEGA, Messenger, MYC, Gastrointestinal cancer, HCC, Society, COVID, Cryptocurrency, Pharmaceutical industry, Medical imaging

“2022 was a pivotal year for Omega, marked by tremendous progress and consistent execution.

Key Points: 
  • “2022 was a pivotal year for Omega, marked by tremendous progress and consistent execution.
  • Research and development (R&D) expenses for the fourth quarter of 2022 were $25.7 million, compared to $14.7 million for the fourth quarter 2021.
  • General and administrative (G&A) expenses for the fourth quarter of 2022 were $5.4 million, compared with $5.7 million for the fourth quarter of 2021.
  • Net loss for the fourth quarter of 2022 was $30.8 million, compared with $20.9 million for the fourth quarter of 2021.

H&E Equipment Services, Inc. Reports Fourth Quarter and Full Year 2022 Results

Retrieved on: 
Wednesday, February 22, 2023
Automotive, Other Construction & Property, Manufacturing, Construction & Property, Fleet Management, Machinery, EBITDA, Depreciation, SG, Komatsu, Net income, Eastern Time Zone, GAAP, Acquisition, Pressure, Security (finance), Growth, Total, Tax, Optimism, Environment, Generally Accepted Accounting Principles (United States), OEC, Adobe Acrobat, Sale, Renting, FINANCIAL, Cryptocurrency, Video game, Bookkeeping, Renewable energy, Adjustment

Gross margin of 45.1% for the fourth quarter of 2022 compared to 42.0% for the fourth quarter of 2021.

Key Points: 
  • Gross margin of 45.1% for the fourth quarter of 2022 compared to 42.0% for the fourth quarter of 2021.
  • Time utilization (based on original equipment cost) was 72.0% in the fourth quarter of 2022 compared to 73.1% in the fourth quarter of 2021.
  • Gross margins on new equipment sales were 13.6% in the fourth quarter of 2022 compared to 14.5% in the fourth quarter of 2021.
  • Interest expense was $13.5 million for the fourth quarter of 2022, or essentially unchanged from the fourth quarter of 2021.

Germany Toy Market Report 2023-2028: Industry Trends, Growth, Insights, & Company Analysis Featuring Mattel, Hasbro, LEGO Group, Ravensburger, Spin Master, & Vetch - ResearchAndMarkets.com

Retrieved on: 
Friday, February 17, 2023
Retail, Toys, The arts, Science, VTech, Segment, Lego Super Mario, Discounted cash flow, Outdoor, LEGO, Safety, Imagination, Government, Patient, Infant, E-commerce, SME, Child, Parent, DSM-IV codes, Electronics, Department store, International Art & Craft Fair, Alzheimer's disease, The Lego Group, US, Action figure, Creativity, Video, Dementia, Cognition, Toy, OEC, Growth

The "Germany Toy Market, Size, Forecast 2023-2028, Industry Trends, Growth, Insights, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Germany Toy Market, Size, Forecast 2023-2028, Industry Trends, Growth, Insights, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Germany Toy Market is determined to reach US$ 6.76 Billion at a CAGR of 3.51% at the end year 2028.
  • As children's toy desires change quickly, the industry needs to establish the latest products to meet these changing desires continuously.
  • In June 2022, The LEGO Group brings 2-player action to the LEGO Super MarioT universe with LEGO MarioT and LEGO Luigi.

Orion Achieves Gold Rating, Higher Sustainability Score From EcoVadis

Retrieved on: 
Wednesday, February 15, 2023
Professional Services, Chemicals, Plastics, Environmental, Social and Governance (ESG), Environment, Manufacturing, Sustainability, Gold, Orion, Ethics, NYSE, Plant, Overalls, OEC, Recycling, Platinum

Orion Engineered Carbons (NYSE: OEC), a global specialty chemicals company, announced today it has received a Gold medal rating from EcoVadis, an independent organization that assesses the performance of companies in a wide range of sustainability areas.

Key Points: 
  • Orion Engineered Carbons (NYSE: OEC), a global specialty chemicals company, announced today it has received a Gold medal rating from EcoVadis, an independent organization that assesses the performance of companies in a wide range of sustainability areas.
  • Orion improved its score from the previous year, moving up from 72 to 77 points – just one point away from receiving a Platinum medal rating.
  • The company is now in the 99th percentile of companies assessed by EcoVadis.
  • Orion’s most recent sustainability initiatives have included installing control equipment at its U.S. plants that is substantially reducing emissions.

United Rentals Announces Record Fourth Quarter and Full-Year1 2022 Results, Introduces 2023 Outlook, Dividend Program and Restart of Share Repurchase Program

Retrieved on: 
Wednesday, January 25, 2023
Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Public expenditure, Bank statement, EPS, Item, Regulation S-K, Note, Acquisition, EBITDA, Tax Cuts and Jobs Act of 2017, Capital, GAAP, Senior, Absorption, Tax, OEC, United Rentals, ABL, Share repurchase, Regulation, Calendar, Depreciation, Borrowing base, Film industry, Car rental, Renting, Bookkeeping, Cryptocurrency

The increases in rental revenue, fleet productivity and average OEC include the impact of the December 2022 Ahern Rentals acquisition.

Key Points: 
  • The increases in rental revenue, fleet productivity and average OEC include the impact of the December 2022 Ahern Rentals acquisition.
  • Net income for the quarter increased 32.8% year-over-year to $639 million, while net income margin increased 210 basis points to 19.4%.
  • Adjusted EBITDA for the quarter increased 25.8% year-over-year to a fourth quarter record of $1.647 billion, while adjusted EBITDA margin increased 280 basis points to 50.0%.
  • General rentals segment had an increase of 19.1% year-over-year in rental revenue to a fourth quarter record of $2.023 billion.

Orion Sharply Reduces Air Emissions with New Technology at Borger, Texas, Plant

Retrieved on: 
Tuesday, January 24, 2023
Professional Services, Philanthropy, Environmental, Social and Governance (ESG), Chemicals, Plastics, Environment, Manufacturing, Other Philanthropy, Orion, OEC, Electricity, Table tennis rubber, Sulfur dioxide, NYSE, COVID-19, Plant, Renewable energy

Orion Engineered Carbons (NYSE: OEC), a global specialty chemicals company, said today it will sharply reduce air emissions at its Borger, Texas, plant with new control technology.

Key Points: 
  • Orion Engineered Carbons (NYSE: OEC), a global specialty chemicals company, said today it will sharply reduce air emissions at its Borger, Texas, plant with new control technology.
  • “Investing in emissions control technology and generating more clean energy are key to our commitment to sustainability,” Orion CEO Corning Painter said.
  • Orion also recently upgraded its emissions control technology at facilities in Ivanhoe, Louisiana and Orange, Texas.
  • Later this year, Orion plans to finish its final U.S. emissions project at its site in Belpre, Ohio.

Orion Engineered Carbons Announces Full Year and Fourth Quarter 2022 Earnings Release Date and Conference Call Information

Retrieved on: 
Tuesday, January 17, 2023
Chemicals, Plastics, Other Manufacturing, Manufacturing, EST, NYSE, OEC, Pharmaceutical industry

Orion Engineered Carbons (NYSE: OEC), a specialty chemical company, today announced that the company will release its full year and fourth quarter 2022 results after the market closes on Thursday, February 16, 2023, to be followed by a conference call on Friday, February 17, 2023, at 8:30 a.m. (EST).

Key Points: 
  • Orion Engineered Carbons (NYSE: OEC), a specialty chemical company, today announced that the company will release its full year and fourth quarter 2022 results after the market closes on Thursday, February 16, 2023, to be followed by a conference call on Friday, February 17, 2023, at 8:30 a.m. (EST).
  • The dial-in details for the live conference call are as follow:
    A replay of the conference call may be accessed by phone at the following numbers through February 24, 2023:

Hair Wigs and Extensions Global Market Report 2022: Growing Occurrence of Hair Related Problems Fuels Demand - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 10, 2023
Retail, Other Retail, United States National Library of Medicine, Hair, Hair loss, The Observatory of Economic Complexity, Woman, Growth, National library, Consciousness, OEC, Revenue, Complexity, Nature, USD, Beauty salon, Cosmetics, Toy, Telecommunication, Futura

The global hair wigs and extensions market size is expected to reach USD 11.8 billion by 2030, according to a new study.

Key Points: 
  • The global hair wigs and extensions market size is expected to reach USD 11.8 billion by 2030, according to a new study.
  • The growing use of hair extensions and head hair wigs is trending today.
  • The global players include Evergreen Products Group, Paula Young, HairUWear, Aderans, Donna Bella, Longlocks, Ruimei Hair Products, ALERIANA Wigs, Klix Hair, Indique Hair, and Shake-N-Go, among others.
  • The publisher has segmented the hair wigs and extensions market report based on product, hair type, and region:
    Hair Wigs and Extensions, Product Outlook (Revenue - USD Billion, 2018 - 2030)
    Hair Wigs and Extensions, Hair Type Outlook (Revenue - USD Billion, 2018 - 2030)
    Hair Wigs and Extensions, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

Omega Therapeutics to Present Trial-in-Progress Poster for Phase 1/2 MYCHELANGELO™ I Study at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium

Retrieved on: 
Tuesday, January 17, 2023
Therapy, RNA transfection, MYC, Standard of care, Pharmacokinetics, Hepatocellular carcinoma, Safety, Poster, Gastrointestinal cancer, Patient, OEC, HCC, Society, American Society of Clinical Oncology, Pharmaceutical industry, Dietary supplement

CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenetic mRNA medicines, today announced that it will present a trial-in-progress poster at the upcoming American Society for Clinical Oncology 2023 Gastrointestinal Cancers Symposium (ASCO-GI), taking place in San Francisco, Calif., and virtually, January 19–21, 2023.

Key Points: 
  • CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenetic mRNA medicines, today announced that it will present a trial-in-progress poster at the upcoming American Society for Clinical Oncology 2023 Gastrointestinal Cancers Symposium (ASCO-GI), taking place in San Francisco, Calif., and virtually, January 19–21, 2023.
  • The poster will highlight the design of the ongoing MYCHELANGELO™ I study, a Phase 1/2 open-label trial evaluating OTX-2002, a first-in-class Omega Epigenomic Controller™ (OEC) candidate, for the treatment of hepatocellular carcinoma (HCC) and other solid tumor types known for association with the c-Myc (MYC) oncogene.
  • Details for the ASCO Gastrointestinal Cancers Symposium Trial-in-Progress poster presentation are as follows:
    Title: A phase 1/2 open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of OTX-2002 as a single agent and in combination with standard of care in patients with hepatocellular carcinoma and other solid tumor types known for association with the MYC oncogene (MYCHELANGELO I).
  • The poster will be made available on the Omega website at https://omegatherapeutics.com/our-science/#publications-research at the same time as the presentation.

Ormat Secured a Financing Agreement for the Development of Ijen Geothermal Project

Retrieved on: 
Thursday, January 12, 2023
Climate change, MCG, Speech, MedcoEnergi, USAID, SMI, Resource management, Ministry, NYSE, Riau, Partnership, CCPP, PT, OEC, Ministry of Energy and Mineral Resources (Indonesia), ORA, Renewable energy, Ijen, Ormat Technologies

RENO, Nev., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA) - Ormat Technologies (NYSE: ORA) and PT Medco Power Indonesia (“Medco Power”) through their subsidiary company, PT Medco Cahaya Geothermal (“MCG”), signed a Financing Agreement with PT Sarana Multi Infrastruktur (Persero) (“SMI”) for development of Ijen Geothermal Power Plant.

Key Points: 
  • RENO, Nev., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA) - Ormat Technologies (NYSE: ORA) and PT Medco Power Indonesia (“Medco Power”) through their subsidiary company, PT Medco Cahaya Geothermal (“MCG”), signed a Financing Agreement with PT Sarana Multi Infrastruktur (Persero) (“SMI”) for development of Ijen Geothermal Power Plant.
  • The Ijen power plant will be developed in stages with the first phase of the development is expected to generate 34 MW in 2025.
  • MCG, a jointly owned company between Medco Power (51% equity share) and Ormat Technologies (49% equity share), will develop and operate the first geothermal power plant in East Java.
  • Ormat also signed a contract as a key contractor on OEC supply for this project.